home / stock / gnta / gnta message board
Subject | By | Source | When |
---|---|---|---|
FDAs decision to grant Orphan Drug Designation to | Luckypennyman | investorshub | 03/02/2023 3:17:27 PM |
$GNTA: Just got a $15 PriceTarget upgrade. | makinezmoney | investorshub | 01/05/2023 2:59:42 PM |
Maxim starts Genenta Science at buy; PT $21 | conix | investorshub | 01/18/2022 8:55:03 PM |
is this genta that we have before, it | asser_al7ob | investorshub | 01/15/2022 4:41:36 AM |
Clinical-stage biotechnology company pioneering | Phosphene | investorshub | 12/28/2021 7:57:58 PM |
News, Short Squeeze, Breakout and More Instantly...
Genenta Science S.p.A. Company Name:
GNTA Stock Symbol:
NASDAQ Market:
Genenta Science S.p.A. Website:
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 46.5% to $0.2183 on volume of 404,016,812 shares NVIDIA Corporation (NVDA) rose 2.6% to $121.09 on volume of 317,123,916 shares PROSHARES TRUST (SQQQ) rose 1.5% to $8.23 on volume of 207,449,647 shares Max...
MILAN, Italy and NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a clinical-stage immuno-oncology company developing a cell-based platform harnessing the power of hematopoietic stem cells to provide durable and safe treatments for solid tumors, announces that ...